Euparen Multi (bejdsemiddel)

Primær information

  • Handelsnavn:
  • Euparen Multi (bejdsemiddel) Pulver
  • Lægemiddelform:
  • Pulver
  • Sammensætning:
  • 500 g/kg tolylfluanid
  • Brugt til:
  • Planter
  • Medicin typen:
  • agrokemiske

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • Euparen Multi (bejdsemiddel) Pulver
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • SEGES Landbrug & Fødevarer
  • Autorisation status:
  • Udgået
  • Autorisationsnummer:
  • 18-396
  • Sidste ændring:
  • 08-02-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.

19-4-2018

April 4, 2018: Fences Indicted in Multi-Million Dollar, Multi-State Criminal Theft Operations

April 4, 2018: Fences Indicted in Multi-Million Dollar, Multi-State Criminal Theft Operations

April 4, 2018: Fences Indicted in Multi-Million Dollar, Multi-State Criminal Theft Operations

FDA - U.S. Food and Drug Administration

18-4-2018

24-Hour Multi-Patient Use Endoscope Connectors: Letter to HealthCare Providers and Healthcare Facilities - Risk of Cross-Contamination

24-Hour Multi-Patient Use Endoscope Connectors: Letter to HealthCare Providers and Healthcare Facilities - Risk of Cross-Contamination

the recommended instructions and device design for the ERBEFLO port connector do not adequately mitigate the risks of cross-contamination for endoscopy patients. This is because the connector, tubing, and/or water bottle can become contaminated with blood, stool, or other fluids from previous patients that travel back through the endoscope channels into the connector and tubing. Endoscope connectors that are labeled for use with multiple patients over the course of 24 hours without reprocessing are kno...

FDA - U.S. Food and Drug Administration

16-3-2018

"Beyond Yourself Multi Athlete" and unauthorized bulk "Multi-Vitamines" seized from Shop Santé stores in Quebec may pose serious health risks

"Beyond Yourself Multi Athlete" and unauthorized bulk "Multi-Vitamines" seized from Shop Santé stores in Quebec may pose serious health risks

Health Canada is advising Canadians that "Beyond Yourself Multi Athlete" multivitamin and unauthorized "Multi-Vitamines" sold in bulk were seized from several Shop Santé stores in Quebec because they may pose serious health risks.

Health Canada

26-2-2018

FDA Drug Safety Communication: FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients

FDA Drug Safety Communication: FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients

[2-25-2015] In an effort to reduce the serious risk of infection spread through sharing of multi-dose diabetes pen devices intended for single patient use only, the U.S. Food and Drug Administration (FDA) is requiring additional label warnings prohibiting sharing of these injectable medicines.

FDA - U.S. Food and Drug Administration

22-1-2018

Flawless Beauty, LLC Issues Voluntary Recall of Unapproved Drugs

Flawless Beauty, LLC Issues Voluntary Recall of Unapproved Drugs

Ocean Township, NJ. In accordance with a Consent Decree of Permanent Injunction ordered in the United States District Court for the District of New Jersey, Flawless Beauty, LLC is voluntarily recalling all lots of nineteen different products sold individually or as part of multi-unit kits alleged by the U.S. Food and Drug Administration ("FDA") to be misbranded or unapproved new drugs pursuant to the Federal Food, Drug, and Cosmetic Act. The FDA believes that these drugs present serious public health risks.

FDA - U.S. Food and Drug Administration

26-3-2018

MULTI-PURPOSE SKIN PROTECTANT (A And D Ointment) Ointment [CVS Pharmacy]

MULTI-PURPOSE SKIN PROTECTANT (A And D Ointment) Ointment [CVS Pharmacy]

Updated Date: Mar 26, 2018 EST

US - DailyMed